Dr. Michael Taylor
Co-Leader, Brain Cancer TRI
Dr. Michael Taylor is a paediatric neurosurgeon and senior scientist at the Hospital for Sick Children. He co-leads OICR’s Brain Cancer Translational Research Initiative.
Dr. Taylor’s laboratory focuses on the genetics of paediatric medulloblastoma and ependymoma, two of the most common malignant paediatric brain tumours. Through a better understanding of the molecular biology of these tumours, Dr. Taylor’s lab hopes to devise novel, more effective treatment strategies.
Dr. Taylor is also a principal investigator at the Arthur and Sonia Labatt Brain Tumour Research Centre. He has appointments at the Developmental & Stem Cell Biology Program at the SickKids Research Institute, the Department of Surgery at the University of Toronto and the Department of Laboratory Medicine and Pathobiology at the University of Toronto.
- Co-Leader, Brain Cancer Translational Research Initiative
- Staff Neurosurgeon, The Hospital for Sick Children
- Professor, Surgery, University of Toronto
- Senior Scientist, The Hospital for Sick Children
- Brain cancer
- Cancer genetics
- Molecular biology
- Garzia L, Kijima N, Morrissey AS, …, Taylor MD. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases. Cell. 2018; 173(6):1549.
- Mack SC, Pajtler KW, Chavez L, …, Taylor MD, Rich JN. Therapeutic targeting of ependymoma as informed by enhancer profiling. Nature. 2018; 553(7686):101-105.
- Northcott PA, Buchhalter I, Morrissey AS, …, Taylor MD, Lichter P. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017;547(7663):311-317.
- Cavalli FMG, Remke M, Rampasek L, …, Taylor MD. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017;31(6):737-754.e6.
- Morrissy AS, Cavalli FMG, Remke M, …, Taylor MD. Spatial Heterogeneity in medulloblastoma. Nat Genet. 2017;49(5):780-788.
- Morrissy AS, Garzia L, Shih DJH, …, Taylor MD. Divergent clonal selection dominates medulloblastoma at recurrence. Nature. 2016; 529(7586):351-7.
- Ramaswamy V, Hielscher T, Mack SC, …, Taylor MD. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. J Clin Oncol. 2016; 34(21):2468-77.
- Canadian Cancer Society, William E. Rawls Prize, 2015
- The Hospital for Sick Children and the University of Toronto, Garron Family Endowed Chair in Childhood Cancer Research, 2013
- George-Armstrong Peters Research Award for Research Excellence in Surgery, 2011
- Royal College of Physicians and Surgeons of Canada, Gold Medal in Surgery, 2010
- Canadian Institutes of Health Research, Clinician-Scientist Phase II Award, 2007, 2010
- Canadian Cancer Society, Young Investigator Award in Biomedical Science, 2009
- Caldwell Partners, Canada’s Top 40 Under 40, 2008
- PhD, University of Toronto
- MD, University of Western Ontario
Opportunities to collaborate
To collaborate with Dr. Taylor, please contact him directly.
Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.
Dr. Michael Taylor